Literature DB >> 2107634

Primary lipid cardiomyopathy.

A Zimmermann1, P Wyss, F Stocker.   

Abstract

In this communication, we describe an isolated, apparently congenital cardiomyopathy (CMP) characterized by the accumulation of stainable lipid in mitochondria of cardiomyocytes. This lesion, which we term primary lipid cardiomyopathy, has not been reported so far. The structural alteration was associated with progressive heart failure, leading to death at the age of 3 years, and with massive hypertrophy of myocardium. Lipid storage in heart muscle cells resulted in an impressive yellow to orange color of the myocardium. We suggest that this type of primary CMP may represent a new member within the group of mitochondrial CMPs. Possible pathogenic mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107634     DOI: 10.1007/bf01605153

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  62 in total

1.  Congenital cataract and mitochondrial myopathy of skeletal and heart muscle associated with lactic acidosis after exercise.

Authors:  R C Sengers; J M Trijbels; J L Willems; O Daniels; A M Stadhouders
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

2.  A MYOPATHY PRESENTING IN ADULT LIFE WITH FEATURES SUGGESTIVE OF GLYCOGEN STORAGE DISEASE.

Authors:  J M Holmes; C R Houghton; A L Woolf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-11       Impact factor: 10.154

3.  Cytochrome c oxidase deficiency in infancy.

Authors:  A Oldfors; H Sommerland; E Holme; M Tulinius; B Kristiansson
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency.

Authors:  D M Turnbull; K Bartlett; D L Stevens; K G Alberti; G J Gibson; M A Johnson; A J McCulloch; H S Sherratt
Journal:  N Engl J Med       Date:  1984-11-08       Impact factor: 91.245

5.  [Mucolipidosis type II (I-cell disease) with unusually severe heart involvement].

Authors:  R Schulz; J Vogt; W Voss; F Hanefeld
Journal:  Monatsschr Kinderheilkd       Date:  1987-10       Impact factor: 0.323

6.  Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.

Authors:  C R Roe; D S Millington; D A Maltby; T P Bohan; S G Kahler; R A Chalmers
Journal:  Pediatr Res       Date:  1985-05       Impact factor: 3.756

7.  Metabolism of neutral lipids in cultured fibroblasts from multisystemic (or type 3) lipid storage myopathy.

Authors:  J Radom; R Salvayre; A Negre; A Maret; L Douste-Blazy
Journal:  Eur J Biochem       Date:  1987-05-04

8.  [Lipid myopathy: a heterogenic familial case].

Authors:  T Kuntzer; D Robert; J Cox; C Meier; A Schwartz; G Guelpa; C E Pfister
Journal:  Schweiz Med Wochenschr       Date:  1987-12-12

9.  Autosomal dominant syndrome of lipid neuromyopathy with normal carnitine: successful treatment with long-chain fatty-acid-free diet.

Authors:  V Askanas; W K Engel; H H Kwan; N B Reddy; T Husainy; J Carlo; T Siddique; R J Schwartzman; C J Hanna
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

10.  Cardiomyopathy and short stature associated with mitochondrial and/or lipid storage myopathy of skeletal muscle.

Authors:  R C Sengers; A M Stadhouders; H H Jaspar; J M Trijbels; O Daniels
Journal:  Neuropadiatrie       Date:  1976-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.